14.16
-2.68%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Zhejiang Xinguang Pharmaceutical Co
Its shares trade on Shenzhen under the ticker 300519.SZ. It has been listed since 24 June 2016. In the fiscal year to 31 December 2025, it reported revenue of CN¥265.4m and net income of CN¥54.2m. At that date it held total assets of CN¥889.4m and shareholders' equity of CN¥836.8m.
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicine and health food. The company is headquartered in Shaoxing, Zhejiang. The company went IPO on 2016-06-24. The main products of the Company are cardiovascular and cerebrovascular diseases medicine as well as traumatic disease medicine. Its other products include the drugs used in respiratory systems, digestive systems, urinary systems, paediatric diseases and immune systems. The firm operates its businesses mainly in domestic markets, with Zhejiang Province as its major market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 24 Jun 2016
- Employees
- 308
- Website
- xgpharma.weba.testwebsite.cn ↗
Leadership
Pay as last reported
- Mr. Yuejun WangExecutive Chairman of the Board, General Manager, since 2012
- Ms. Binbin XingChief Financial Officer, Director, since 2014
- Mr. Zhuping SunChief Marketing Officer, since 2024
- Mr. Yuanyang JiangDeputy General Manager, Secretary of the Board, Director, since 2012
- Mr. Fuyin QiuDeputy General Manager, Director, since 2012
- Mr. Yuyang MaDirector
- Ms. Xiaolin XingDirector
- Ms. Haijing CaiIndependent Director
- Mr. Guiyuan LuIndependent Director
- Mr. Weiguang ShanIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Zhejiang Xinguang Pharmaceutical employs 308 full-time employees in Shaoxing, China.
- The company focuses on cardiovascular and cerebrovascular medicine as core products.
- Zhejiang Province serves as the major market for Zhejiang Xinguang Pharmaceutical.
Weaknesses
- Zhejiang Xinguang Pharmaceutical operates primarily in the domestic Chinese market.
- The company's business is limited to Chinese medicine and health food sectors.
- Zhejiang Xinguang Pharmaceutical has no international presence beyond China.
Opportunities
- Zhejiang Xinguang Pharmaceutical can expand into respiratory system drug markets.
- The company may grow in digestive system drug markets within Zhejiang Province.
- Zhejiang Xinguang Pharmaceutical could develop pediatric disease medicine products.
Threats
- Zhejiang Xinguang Pharmaceutical faces competition from domestic Chinese pharmaceutical firms.
- The company's reliance on domestic markets poses a risk to growth.
- Zhejiang Xinguang Pharmaceutical must navigate regulatory changes in the Chinese Health Care sector.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.